FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

FDA Modernizes Citizen Petition Regs to Include E-Submissions

12/19/2013

Federal Register Final rule: FDA is modernizing its administrative regulations on submitting citizen petitions to explicitly provi...

FDA, CMS Extend Parallel Review Pilot

12/18/2013

Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services have decided to extend the “Pilot Program fo...

Guidance on BE Studies for ANDA Pharmacokinetic Endpoints

12/05/2013

Guidance on BE Recommendations on Paliperidone Palmitate

12/05/2013

FDA Sends OTC Drug Labeling Info to OMB

12/05/2013

Federal Register Notice: FDA proposed collection of information, “Over-the-Counter Drugs; Labeling Requirements,” has ...

Comments Sought on Importer’s Entry Notice

11/27/2013

Comments Extended on Asthma Drug Bioequivalence

11/27/2013

Federal Register Notice: FDA is reopening the comment period for the notice of availability entitled Draft Guidance for Industry o...

Comments Extended on Generic Drug User Fee Guidance

11/27/2013

Federal Register Notice: FDA is reopening the comment period to 12/11 for the Draft Guidance for Industry on Generic Drug User Fee...

Panel to Discuss REMS Communications

11/27/2013

Federal Register Notice: FDA’s Risk Communications Advisory Committee will meet 12/17 from 9 a.m. to 5 p.m. at the FDA White...

FDA Seeks Sponsors for Study Data Pilot

11/27/2013

Federal Register Notice: CDER and CBER are announcing a pilot project to evaluate the Clinical Data Interchange Standard Consortiu...